ACRO Calls for Clarity on FDA Draft Guidance on eSource Trial Data

ACRO is calling on the FDA to clarify draft guidance attempting to mitigate the possible pitfalls in transitioning to electronic source data for clinical investigations.

http://www.in-pharmatechnologist.com/Regulatory-Safety/ACRO-Calls-for-Clarity-on-FDA-Draft-Guidance-on-eSource-Trial-Data?